Dogecoin Cash, Inc (DOGP) Fair Value & Analysis
Healthcare · US · Market cap $1.3M
Fair value as of: Jun 23, 2026
Analysis
Dogecoin Cash, Inc (DOGP) currently trades at $0.0075, while our model-based Fair Value estimate is $0.0100 — implying the stock looks roughly 33.3% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Dogecoin Cash, Inc., through its subsidiaries, provides online telehealth referral services through the PrestoDoctor platform in the United States. The company offers the technology platform and administrative support that facilitate telemedicine consultations between patients and licensed physicians. In addition, it maintains cannabis-related intellectual property. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Dogecoin Cash, Inc (DOGP) undervalued?
What is the fair value of DOGP?
What is the quality score of DOGP?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.